
Where will non-Vitamin K oral anticoagulants stand beyond being standard of care in anticoagulation therapy?
Author(s) -
Oktay Ergene
Publication year - 2019
Publication title -
international journal of the cardiovascular academy
Language(s) - English
Resource type - Journals
eISSN - 2405-819X
pISSN - 2405-8181
DOI - 10.4103/ijca.ijca_14_19
Subject(s) - medicine , warfarin , atrial fibrillation , stroke (engine) , deep vein , edoxaban , population , thrombosis , randomized controlled trial , intensive care medicine , rivaroxaban , mechanical engineering , environmental health , engineering